Integrated BioPharma, Inc. (INBP)
Integrated BioPharma, Inc. operates in the Medical - Pharmaceuticals industry of the Healthcare sector, headquartered in Hillside, NJ, US. The stock last traded at $0.16, up 0.00% on the session, giving a market capitalisation of $5.0M. On trailing twelve-month figures it carries a trailing P/E of -3.00, a net margin of -3.4%. Its beta of 0.35 implies it has historically moved less than the broad market.
Integrated BioPharma, Inc., together with its subsidiaries, engages in the manufacturing, distributing, marketing and sale of vitamins, nutritional supplements, and herbal products primarily in the United States and Luxembourg. The company operates through two segments, Contract Manufacturing and Other Business Lines. The Contract Manufacturing segment manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers, and specialized health-care providers. The Other Nutraceutical Businesses segment provides warehousing and fulfilment services; and distributes raw materials. The company was formerly known as Integrated Health Technologies, Inc. Integrated BioPharma, Inc. was incorporated in 1980 and is based in Hillside, New Jersey.
Integrated BioPharma, Inc. is most often compared with the following Healthcare names: